Literature DB >> 28988523

Immunopathology in drug resistant mesial temporal lobe epilepsy with different types of hippocampal sclerosis.

F Irsel Tezer1, Aysegul Firat2, Erdem Tuzun3, Isik Unal4, Figen Soylemezoglu5, Burcak Bilginer6, Figen Kaymaz4, Kader K Oguz7, Serap Saygi1.   

Abstract

PURPOSE: There is evidence that autoimmunity has a specific role in temporal lobe seizures of limbic encephalitis patients. Our aim in this study was to investigate any histopathological clues of autoimmune process in refractory temporal lobe epilepsy (TLE) patients with different pathologically proven hippocampal sclerosis (HS) types.
METHODS: 22 patients who had undergone epilepsy surgery due to mesial TLE-HS were included. The sera of patients are tested for neuronal antibodies to N-methyl-D-aspartate receptors (NMDAR), leucine-rich, glioma inactivated 1 (LGI1), contactin-associated protein 2 (CASPR2), α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR), gamma-aminobutyric acid B receptor (GABABR) and glutamic acid decarboxylase (GAD). Pathological and immunohistochemical investigations including neuronal nuclei (NeuN), NMDAR, GAD, glial fibrillary acidic protein (GFAP), CD8+-CD3+ lymphocytes and immunoglobulin G (IgG) were done. Patients were grouped according to type of HS. Clinical features and immunohistochemical changes were defined in these groups.
RESULTS: Available sera of 15 patients did not have any neuronal antibodies. Thirteen of 22 patients had HS type 1, three had HS type 2 and two had HS type 3. According to immunohistochemical investigations CD3+ and CD8+ T cell infiltration was more prominent in the hippocampus of patients with classical HS (International League Against Epilepsy (ILAE) Type 1 HS) and there was a significant negative correlation between epilepsy duration and numbers of CD3+-CD8+ lymphocytes in temporal lobe parenchyma.
CONCLUSION: The role of T cell-mediated immunopathology and immunopathological difference in a variety of drug resistant TLE-H2S patients was suggested. These findings can be helpful in understanding the epileptogenicity of HS.

Entities:  

Keywords:  Temporal lobe epilepsy; autoantibodies; hippocampal sclerosis; immunopathology; limbic encephalitis

Mesh:

Substances:

Year:  2017        PMID: 28988523     DOI: 10.1080/00207454.2017.1389928

Source DB:  PubMed          Journal:  Int J Neurosci        ISSN: 0020-7454            Impact factor:   2.292


  4 in total

1.  Reduced cannabinoid 2 receptor activity increases susceptibility to induced seizures in mice.

Authors:  Lindsey Shapiro; Jennifer C Wong; Andrew Escayg
Journal:  Epilepsia       Date:  2019-11-22       Impact factor: 5.864

2.  Impaired hippocampal functional connectivity in patients with drug resistant, generalized tonic-clonic seizures.

Authors:  Zhengge Wang; Xiaoyun Wang; Rong Rong; Yun Xu; Bing Zhang; Zhongyuan Wang
Journal:  Neuroreport       Date:  2019-07-03       Impact factor: 1.837

3.  Do the neurologists recognize autoimmune epilepsy well enough? What is the effect of the pandemic on this matter?

Authors:  Ebru Nur Vanli Yavuz; Ebru Altındağ; Erdem Tüzün; Betül Baykan
Journal:  Neurol Sci       Date:  2022-04-05       Impact factor: 3.830

4.  Chronically reduced IL-10 plasma levels are associated with hippocampal sclerosis in temporal lobe epilepsy patients.

Authors:  Pabitra Basnyat; Marko Pesu; Mikael Söderqvist; Anna Grönholm; Suvi Liimatainen; Maria Peltola; Jani Raitanen; Jukka Peltola
Journal:  BMC Neurol       Date:  2020-06-12       Impact factor: 2.474

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.